Cargando…
Correction to: Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study
Autores principales: | Ruscica, Massimiliano, Pavanello, Chiara, Gandini, Sara, Macchi, Chiara, Botta, Margherita, Dall’Orto, Daria, Del Puppo, Marina, Bertolotti, Marco, Bosisio, Raffaella, Mombelli, Giuliana, Sirtori, Cesare R., Calabresi, Laura, Magni, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734387/ https://www.ncbi.nlm.nih.gov/pubmed/31500629 http://dx.doi.org/10.1186/s12937-019-0483-x |
Ejemplares similares
-
Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study
por: Ruscica, Massimiliano, et al.
Publicado: (2019) -
Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study)
por: Cicolari, Stefania, et al.
Publicado: (2021) -
Effect of repeated oral administration of Bifidobacterium longum BB536 on
apomorphine-induced rearing behavior in mice
por: ORIKASA, Shuzo, et al.
Publicado: (2016) -
Usefulness of Bifidobacterium longum BB536 in Elderly Individuals With Chronic Constipation: A Randomized Controlled Trial
por: Takeda, Tsutomu, et al.
Publicado: (2023) -
Protective effect of Bifidobacterium longum BB536 against nausea caused by pirfenidone in a mouse model of pellagra
por: KURONUMA, Koji, et al.
Publicado: (2023)